Registration number:
Clear Clinical Research Limited
for the Period from 1 November 2023 to 30 April 2025
Clear Clinical Research Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Clear Clinical Research Limited
Company Information
|
Director |
A. J. Thompson |
|
Registered office |
|
|
Accountants |
|
Clear Clinical Research Limited
(Registration number: 08741372)
Balance Sheet as at 30 April 2025
|
30 April |
31 October |
|
|
Fixed assets |
- |
- |
|
Current assets |
|
|
|
Prepayments and accrued income |
|
|
|
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Accruals and deferred income |
( |
( |
|
|
|
|
|
Capital and reserves |
|
|
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
|
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
Clear Clinical Research Limited
(Registration number: 08741372)
Balance Sheet as at 30 April 2025
|
Related party transactions |
|
Transactions with the director |
|
2025 |
At 1 November 2023 |
Advances to director |
Repayments by director |
At 30 April 2025 |
|
Director's loan account |
|
|
( |
( |
|
2023 |
At 1 November 2022 |
Advances to director |
Repayments by director |
At 31 October 2023 |
|
Director's loan account |
|
|
( |
|
The loan brought forward was repaid on 6 April 2024.
For the financial period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
|
......................................... |